This inventor holds 1 USPTO granted patent. Top assignee: Aventis Pharma S.a.. Active years: 2007.
Company Filing History:
Years Active: 2007
Title: The Innovative Contributions of Alain Raynal
Introduction
Alain Raynal is a notable inventor based in Bures sur Yvette, France. He has made significant contributions to the field of biotechnology, particularly in the area of nucleic acid research. His work has implications for the synthesis of novel compounds, which can be of therapeutic interest.
Latest Patents
Alain Raynal holds a patent for a method for obtaining nucleic acids from an environmental sample. This method results in nucleic acids that can be used in the synthesis of novel compounds. The invention focuses on preparing a library of nucleic acids from a sample, which can be utilized for various applications. The patent also includes novel vectors and processes for preparing these vectors or recombinant host cells containing the nucleic acids. Furthermore, it outlines methods for detecting a nucleic acid of interest within the resulting library.
Career Highlights
Raynal is associated with Aventis Pharma S.A., where he has been able to apply his innovative ideas in a professional setting. His work at the company has allowed him to contribute to advancements in pharmaceutical research and development.
Collaborations
Throughout his career, Alain Raynal has collaborated with esteemed colleagues such as Pascale Jeannin and Jean-Luc Pernodet. These collaborations have likely enriched his research and expanded the impact of his inventions.
Conclusion
Alain Raynal's contributions to the field of biotechnology, particularly through his patent on nucleic acid methods, highlight his innovative spirit and dedication to advancing scientific knowledge. His work continues to influence the development of therapeutic compounds and showcases the importance of collaboration in research.